Shares of Inovio Pharmaceuticals Inc. /zigman2/quotes/202993817/composite INO +4.96% rose 1.78% to $8.59 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.80% rising 0.31% to 13,924.91 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.25% falling 0.09% to 34,599.82. This was the stock's third consecutive day of gains. Inovio Pharmaceuticals Inc. closed $25.20 short of its 52-week high ($33.79), which the company reached on June 26th.
The stock outperformed some of its competitors Tuesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.78% fell 0.59% to $112.34, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.03% fell 0.16% to $236.82, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -0.81% fell 0.16% to $56.31. Trading volume (6.0 M) remained 2.7 million below its 50-day average volume of 8.7 M.